Affiliations 

  • 1 Department of Obstetrics & Gynecology, Kwong Wah Hospital, Hong Kong, China
  • 2 Department of Obstetrics & Gynecology, Pantai Hospital Kuala Lumpur, Kuala Lumpur, Malaysia
  • 3 Section of Hematology, Makati Medical Center & Cardinal Santos Medical Center, San Juan, The Philippines
  • 4 Division of Hematology, Department of Medicine, Ramathibodi Hospital, Bangkok, Thailand
  • 5 Department of Obstetrics and Gynecology, Queen Mary Hospital, Hong Kong, China
  • 6 Department of Obstetrics and Gynecology, University of Santo Tomas Hospital, Manila, The Philippines
  • 7 Zuellig Pharma Therapeutics, Singapore, Singapore
  • 8 Division of Gynecologic Oncology, Philippine General Hospital, Manila, The Philippines
  • 9 Department of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei, Taiwan
  • 10 Division of Obstetrics and Gynecology, Cheng Hsin General Hospital, Taipei, Taiwan
  • 11 Department of Obstetrics and Gynecology, University Medical Centre, Ho Chi Minh City, Vietnam
  • 12 Department of Hematology, Ampang Hospital, Selangor, Malaysia
  • 13 Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
Int J Gynaecol Obstet, 2023 Nov;163(2):495-509.
PMID: 37096333 DOI: 10.1002/ijgo.14804

Abstract

Iron deficiency anemia (IDA) is a major health burden among women in Asia. Key issues in IDA management in Asia are under-diagnosis and under-treatment. The lack of Asia-specific guidelines, and suboptimal utilization of treatment compounds the management of IDA. To address these gaps, a panel of 12 experts in obstetrics, gynecology, and hematology from six regions in Asia convened to review current practices and clinical evidence and provide practical guidance on IDA diagnosis and management in Asian women. The Delphi approach was used to obtain objective opinions and attain consensus on statements pertaining to awareness, diagnosis, and management of IDA. In total, 79 statements attained consensus and are summarized to provide guidance on raising awareness of IDA and approaches for improved diagnosis and treatment of IDA among women in various settings: pregnancy, postpartum, heavy menstrual bleeding, gynecologic cancers, and perioperative care. This clinician-led consensus integrates appropriate recommendations based on clinical evidence and best practices and is intended to guide decision making in the management of iron deficiency/IDA in women. The expert panel raises a call for timely diagnosis and utilization of appropriate treatment, including use of high-dose intravenous iron, stringent blood management, and interdisciplinary collaboration, for optimization of IDA management among women in Asia.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.